NM_016169.4(SUFU):c.42_65del (p.10PGPTAPPA[1]) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 15, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001993890.6

Allele description [Variation Report for NM_016169.4(SUFU):c.42_65del (p.10PGPTAPPA[1])]

NM_016169.4(SUFU):c.42_65del (p.10PGPTAPPA[1])

Genes:

LOC130004614:ATAC-STARR-seq lymphoblastoid silent region 2764 [Gene]
SUFU:SUFU negative regulator of hedgehog signaling [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

10q24.32

Genomic location:

Preferred name:

NM_016169.4(SUFU):c.42_65del (p.10PGPTAPPA[1])

HGVS:

NC_000010.11:g.102504194_102504217del
NG_011901.1:g.3541_3564del
NG_021338.1:g.5233_5256del
NM_001178133.2:c.42_65del
NM_016169.4:c.42_65delMANE SELECT
NP_001171604.1:p.10PGPTAPPA[1]
NP_057253.2:p.10PGPTAPPA[1]
LRG_521:g.5233_5256del
NC_000010.10:g.104263949_104263972del
NC_000010.10:g.104263951_104263974del

Links:

dbSNP: rs2062289607

NCBI 1000 Genomes Browser:

rs2062289607

Molecular consequence:

NM_001178133.2:c.42_65del - inframe_deletion - [Sequence Ontology: SO:0001822]
NM_016169.4:c.42_65del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:: Gorlin syndrome
Synonyms:: Basal cell nevus syndrome
Identifiers:: MONDO: MONDO:0007187; MedGen: C0004779; Orphanet: 377; OMIM: PS109400

Name:: Medulloblastoma (MDB)
Synonyms:: Medulloblastoma, somatic; MEDULLOBLASTOMA PREDISPOSITION SYNDROME
Identifiers:: MONDO: MONDO:0007959; MeSH: D008527; MedGen: C0025149; Orphanet: 616; OMIM: 155255; Human Phenotype Ontology: HP:0002885

Recent activity

Clear Turn Off Turn On

Vmn1r-ps113 vomeronasal 1 receptor, pseudogene 113 [Mus musculus]
Vmn1r-ps113 vomeronasal 1 receptor, pseudogene 113 [Mus musculus]
Gene ID:100312542

Gene
Vmn1r-ps111 vomeronasal 1 receptor, pseudogene 111 [Mus musculus]
Vmn1r-ps111 vomeronasal 1 receptor, pseudogene 111 [Mus musculus]
Gene ID:100312540

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002250144	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Feb 15, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002250144

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Feb 15, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002250144.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with SUFU-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant, c.42_65del, results in the deletion of 8 amino acid(s) of the SUFU protein (p.Pro18_Ala25del), but otherwise preserves the integrity of the reading frame.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine